<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: In pediatric patients with abdominal Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, the involvement of the gastrointestinal tract and abdominal lymph nodes are the main presenting feature of the disease </plain></SENT>
<SENT sid="1" pm="."><plain>Chemotherapy is the main treatment modality and could be preceded by surgical excision of the abdominal masses </plain></SENT>
<SENT sid="2" pm="."><plain>To achieve cure or long-term disease-free survival a balance has to be struck between aggressive chemotherapy and the probability of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> secondary to treatment complicated by <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e>, <z:mpath ids='MPATH_81'>perforation</z:mpath> or <z:hpo ids='HP_0002584'>intestinal bleeding</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>F-18 fluorodeoxyglucose-<z:chebi fb="4" ids="30225">positron</z:chebi> emission tomography/computed tomography (F-18 FDG-PET/CT) has been recommended over conventional imaging modalities for the follow-up of these patients and for monitoring treatment response </plain></SENT>
<SENT sid="4" pm="."><plain>As the incidences of postchemotherapy complications are high, the positive predictive value of PET/CT studies in these patients is very low and the false-positive rate is high from <z:hpo ids='HP_0011009'>acute</z:hpo> <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infections</z:e> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>Accordingly, histopathological confirmation of positive lesions on F-18 FDG-PET/CT studies is essential </plain></SENT>
<SENT sid="6" pm="."><plain>This is especially important as post-therapy complications might present with nonspecific and nonurgent symptoms </plain></SENT>
<SENT sid="7" pm="."><plain>At the same time initiating a second course of salvage chemotherapy is risky </plain></SENT>
<SENT sid="8" pm="."><plain>AIM OF STUDY: Retrospectively reviewed F-18 FDG-PET/CT studies for 28 pediatric patients with abdominal Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and diffuse large B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> after their treatment with chemotherapy or surgery </plain></SENT>
<SENT sid="9" pm="."><plain>RESULTS: Four positive studies were found </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> had pathological verification and were because of <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0001845'>inflammation</z:mp> and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> and there was no evidence of viable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="11" pm="."><plain>One patient had multiple recurrent lesions in the abdomen after the initial surgical excision and before starting chemotherapy </plain></SENT>
<SENT sid="12" pm="."><plain>The incidence of <z:hpo ids='HP_0011009'>acute</z:hpo> complications in this series is 10.7% </plain></SENT>
<SENT sid="13" pm="."><plain>CONCLUSION: This study confirms the high incidence of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> and <z:mp ids='MP_0001845'>inflammation</z:mp> after chemotherapy for the abdominal Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and consequently, the incidence of true-positive F-18 FDG studies is low </plain></SENT>
<SENT sid="14" pm="."><plain>This necessitates the need for histopathological confirmation of positive studies </plain></SENT>
</text></document>